ArticleJournal of ovarian research2025
Comparison of efficacy, safety, and economy of recombinant and urinary follicle-stimulating hormone in women with a predicted normal response undergoing assisted reproductive technology.
Leizhen Xia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.